RecallRadar

FDA Drug recall D-0255-2022

Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind

On 2021-12-01 the FDA classified a Class III recall of Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind by Unichem Pharmaceuticals Usa, citing discoloration.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0255-2022
ClassificationClass III
Statusterminated
Initiated2021-10-25
Published2021-12-01
Last updated2026-09-13 11:52 UTC
CompanyUnichem Pharmaceuticals Usa
DistributionUS

Product

Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut Road, Ghaziabad -201 003, India. Manufactured for: Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ 06815, NDC 29300-116-05.

Reason

Discoloration

Identifiers

ndc29300-115-16
ndc29300-115-01
ndc29300-115-05
ndc29300-115-10
ndc29300-116-16
ndc29300-116-01
ndc29300-116-05
ndc29300-116-10
ndc29300-117-16
ndc29300-117-01
ndc29300-117-05
ndc29300-117-10
ndc29300-118-16
ndc29300-118-01
ndc29300-118-05
ndc29300-118-10
code_infoLot #: ZTPM20044, Exp. Date 09/30/2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0255-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.